Evidence map›Paper›PMID 34658539›Full record

ReviewBiospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)2021

Thomas Rexer, Tuan Hoang Son, Johannes Ruhnau, Udo Reichl

Open access · hybridAbstract readEnglish AbstractReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Cell-freeFrontiers in molecular biosciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Thomas RexerAbteilung Bioprozesstechnik (BPT), Max-Planck-Institut für Dynamik komplexer technischer Systeme, Sandtorstraße 1, D-39106 Magdeburg, Deutschland.
Tuan Hoang SonAbteilung Bioprozesstechnik (BPT), Max-Planck-Institut für Dynamik komplexer technischer Systeme, Sandtorstraße 1, D-39106 Magdeburg, Deutschland.
Johannes RuhnauAbteilung Bioprozesstechnik (BPT), Max-Planck-Institut für Dynamik komplexer technischer Systeme, Sandtorstraße 1, D-39106 Magdeburg, Deutschland.
Udo ReichlAbteilung Bioprozesstechnik (BPT), Max-Planck-Institut für Dynamik komplexer technischer Systeme, Sandtorstraße 1, D-39106 Magdeburg, Deutschland.
Max Planck Institute for Dynamics of Complex Technical Systems · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The field of synthetic glycobiotechnology encompasses the synthesis and modification of free carbohydrates and carbohydrates linked to biomolecules. Our group develops bio-catalytic processes for the synthesis of carbohydrate building blocks, so-called sugar nucleotides, and cell-free multi-enzyme cascades to tailor carbohydrates linked to proteins. The technology can eventually help to advance our understanding of the roles of specific carbohydrates in nutrition and medicine and contribute to human health and well-being.

Identifiers

PMID34658539
PMCPMC8501375
OpenAlexW4200623424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.